Aratana Therapeutics CEO Steven Peter's 2018 pay falls 26% to $2.1M
Aratana Therapeutics reports 2018 executive compensation
By ExecPay News
Published: April 19, 2019
Aratana Therapeutics reported fiscal year 2018 executive compensation information on April 19, 2019.
In 2018, three executives at Aratana Therapeutics received on average a compensation package of $1.3M, a 4% decrease compared to previous year.
Average pay of disclosed executives at Aratana Therapeutics
Steven St. Peter, Chief Executive Officer, received $2.1M in total, which decreased by 26% compared to 2017. 31% of Peter's compensation, or $655K, was in stock awards. Peter also received $247K in non-equity incentive plan, $649K in option awards, $528K in salary, as well as $11K in other compensation.
Craig A. Tooman, Chief Financial Officer, received a compensation package of $864K, which decreased by 9% compared to previous year. 42% of the compensation package, or $360K, was in salary.
Brent Standridge, Chief Operating Officer, earned $800K in 2018, a 30% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 19, 2019.